A Look At Cartesian Therapeutics Inc (NASDAQ: RNAC): How Much Is It Worth And How Should It Be Assessed?
Cartesian Therapeutics Inc (NASDAQ:RNAC)’s traded shares stood at 0.3 million during the last session, with the company’s beta value hitting 0.60. At the close of